SANTA CLARA, Calif.--(BUSINESS WIRE)--Jan. 5, 2006--Ilypsa, Inc., a privately-held biopharmaceutical company pioneering novel non-absorbed polymeric drugs for renal and metabolic disorders, today announced the appointment of Jay P. Shepard as President and Chief Executive Officer. Mr. Shepard will also join the company’s board of directors.
